Pine Pharmaceuticals, LLC

FDA recalling firm · 6 enforcement events · 24 product records · 2015–2023 · NY

Pine Pharmaceuticals, LLC has 6 FDA enforcement events on this register (24 product records) between 2015 and 2023: 6 drug; the busiest year was 2022 with 2.

0% of its events are Class I; the most common class is Class II (4). 0 events are listed as ongoing; the recalling firm's address is in NY.

Recall classification reflects the relative degree of health hazard. Event counts depend on a firm's size and product range; they are not a comparison of one firm with another.

Enforcement events

Initiated	Product (first record)	Type	Class	Records	Status
2 Oct 2023	Bevacizumab 1.25 MG/0.05 ML Solution for Injection, 1 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.	Drug	Class II	16	Terminated
27 Mar 2023	Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in individually labeled poly envelopes (primary packaging). Repackaged by Pine Pharmaceuticals, Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150, Office Use Only, Not for Resale. Secondary…	Drug	Class III	1	Terminated
22 Dec 2022	Epi-Caine, Epinephrine 0.025% Lidocaine HCL 0.75% Solution for Intraocular Injection, 1 ml, Single Dose Vial, Compounded by Pine Pharmaceuticals, 355 Riverwalk Pkwy, Tonawanda, NY 14150. NDC 69194-0948-1	Drug	Class II	1	Terminated
27 Jul 2022	Bupivacaine HCl 0.375% w/v and Lidocaine HCl 2% w/v Solution for Retrobulbar or Peribulbar Injection; packaged in a) 10 mL prefilled syringe, Item# 803, barcode 6919408031; b) 5 mL prefilled syringe, Item# 933, barcode 6919409331, Rx only, Pine Pharmaceuticals, 355 Riverwalk Parkway, Tonawanda, NY 14150.	Drug	Class II	1	Terminated
5 Mar 2018	Brilliant Blue G for Intraocular Injection 0.5mL vial 0.25 mg/mL Compounded by: Pine Pharmaceuticals 355 Riverwalk Pkwy Tonawanda, NY 14150. NDC 69194-0358-01	Drug	Class III	1	Terminated
4 Nov 2015	Bevacizumab 1.25 mg/0.05 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.	Drug	Class II	4	Terminated

By type and class

Drug6

Class II4

Class III2

Class I: 0% of this firm's events; 18% of all events on the register.

Events by year

Enforcement events for Pine Pharmaceuticals, LLC by year initiated.

Questions and answers

How many FDA recalls has Pine Pharmaceuticals, LLC had?

6 enforcement events (24 product records) on this register, 2015–2023: 6 drug.

Are any Pine Pharmaceuticals, LLC recalls ongoing?

0 events are listed as ongoing in the current openFDA export.

What class are Pine Pharmaceuticals, LLC recalls?

4 Class II, 2 Class III. 0% are Class I against 18% of all events on the register. Class reflects the relative degree of health hazard of the product, not the firm.

Where does this data come from?

openFDA food, drug and device enforcement reports (CC0), export dated 28 Sep 2026.

Provenance

Source: openFDA enforcement reports (CC0), export dated 28 Sep 2026. Firm names are grouped exactly as FDA spells them; the same company can appear under several spellings. Only organisations are shown. See the methodology.